Page 100 - Contract Development News Today

Vancouver, BC –  January 25, 2021 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) (“BioVaxys” or “Company”) is pleased to provide a corporate update on recent advancements of its vaccine platforms, viral diagnostic and corporate objectives for 2021. BioVaxys is pleased to announce that it has commenced the clinical development program for BVX-0918A, its haptenized tumor antigen vaccine for ovarian cancer. The Company plans to seek a compassionate use approval in th...

Share this article Share this article - Piramal Pharma Solutions (PPS) is providing drug product formulation and manufacturing from the companys Lexington, KY site in the U.S. - Drug product material will be used in a first-in-humans clinical study MUMBAI, India, Jan. 25, 2021 /PRNewswire/ -- Piramal Pharma Limiteds Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), today announced that it is providing Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX...

Regulatory News: Eurofins (Paris:ERF): Before the annual meeting of 300 of its Business Unit leaders on 26 January 2021, Eurofins pre-announces some of its 2020 results. December 2020

Share: Pune, India, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The global Biopharmaceutical CMO Market is projected to showcase an impressive growth owing to the increasing need to outsource the manufacturing process in the biopharmaceutical industry, observes Fortune Business Insights™ in an upcoming report, these organizations allow pharmaceutical companies to outsource some aspects of their business, which saves their valuable time and aids them to focus on the development of drugs. While making...

22 gennaio 2021 07:37 Fonte: Adnkronos #salute-e-benessere - BOULDER, Colo., Jan. 21, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, Colorado site. Effective February 1, 2021, David Stewart will join the Boulder team as the General Manager/Site Head. Mr. St...

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site USA - English Share this article Share this article BOULDER, Colo., Jan. 21, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, Colorado site. Effective Febr...

(2) NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage forms Centers of excellence employing a total of 390 staff offer expertise in Lipid Oral Dosage Forms including softgels and liquid-filled hard capsules for the pharma and nutrition markets Sustainable growth and people development a...

Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce $76M in Funding for Manufacturing and Innovation Center News provided by Share this article Share this article TOKYO, Jan. 14, 2021 /PRNewswire/ -- FUJIFILM Corporation (COO: Kenji Sukeno) and the Center for Advanced Biological Innovation and Manufacturing (CABIM), today announced that it has secured $76 million in financing and signed a lease for a 40,000 square-foot site in Watertown, Massachusetts at The ...

Share this article Share this article ResearchAndMarkets.coms offering. Asia-Pacifics pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the rising demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures. Highlighted with 44 tables and 53 figures, this 136-page report "Asia-Pacific Pharmaceutical Contract Development and Manufac...

Share this article Share this article LISBON, Portugal, Jan. 12, 2021 /PRNewswire/ -- Hovione, the leader in Pharmaceutical Spray Drying, today announced the launch of ASD-HIPROS, a proprietary screening service for spray dried dispersions. This platform is the most advanced and most accurate tool to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying (ASDs). During drug development, it is crucial to quickly find the optimal formulation assuring fast...